Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Bolus and Continuous Hydration Regimens for the Prevention of Contrast-Associated Acute Kidney Injury
NCT07286526Phase 4Completed
- Start
- Aug 2024
- Primary completion
- Mar 2025
- Countries
- 1
01
Overview
A Phase 4 trial of sodium chloride in contrast-associated acute kidney injury (CA-AKI). Started Aug 2024; status: completed.
02
Drugs
sodium chloride
03
Conditions
contrast-associated acute kidney injury (CA-AKI)
Beyond the preview
Go deeper on NCT07286526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07286526.